Filing Details
- Accession Number:
- 0001209191-17-039137
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-12 16:12:39
- Reporting Period:
- 2017-06-08
- Filing Date:
- 2017-06-12
- Accepted Time:
- 2017-06-12 16:12:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1481512 | Ra Pharmaceuticals Inc. | RARX | Pharmaceutical Preparations (2834) | V8 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1114448 | Ag Novartis | Lichtstrasse 35 Basel V8 4056 | No | No | Yes | No | |
1297709 | Ltd Bioventures Novartis | C/O Novartis International Ag Wsj-200.220 Basel V8 CH-4002 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-06-08 | 700 | $22.00 | 2,307,877 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The board of directors of Novartis Bioventures Ltd. has sole voting and investment control and power over such securities. None of the members of its board of directors has individual voting or investment power with respect to such securities and each disclaims beneficial ownership of such securities. Novartis Bioventures Ltd. is an indirectly owned subsidiary of Novartis AG.